Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies
Clinical trial NCT06909474 · RECRUITING
Trial details
- NCT number
- NCT06909474
- Sponsor
- Chongqing Precision Biotech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2027-03-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.